Description

Mal-PEG8-Val-Cit-PAB-MMAF is a drug-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAF contains a cleavable ADC linker and a potent tubulin inhibitor MMAE (HY-15162)[1].–20°C, 3 years; 4°C, 2 years (Powder)-Applications–Formula-C81H129N11O24-Citation–References-[1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.-CASNumber–MolecularWeight-1640.95-Compound Purity-96.50-SMILES-O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCN1C(C=CC1=O)=O)N[C@H](C(N[C@H](C(NC2=CC=C(COC(N([C@H](C(N[C@H](C(N([C@H]([C@@H](CC(N3[C@]([H])([C@@H]([C@H](C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)C)OC)CCC3)=O)OC)[C@H](CC)C)C)=O)C(C)C)=O)C(C)C)C)=O)C=C2)=O)CCCNC(N)=O)=O)C(C)C-Research_Area-Cancer-Solubility-10 mM in DMSO-Target-Drug-Linker Conjugates for ADC-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related